Nimetazepam

Drug #1285

Nimetazepam is a benzodiazepine with actions andadverse effects similar to those of diazepam. Nimetazepam is given orally for the short-term management of insomnia.

← Previous drug Next drug →

Primary Characteristics

It is of Synthetic origin and belongs to Benzodiazepines.

Molecular Weight: 295.3 · Non-proprietary name: Nimetazepam.

Pharmacokinetics

Distribution: Nimetazepam has a plasma protein binding is 87%.

Elimination: it is metabolised via Hepatic, plasma half-life is 24-30 hr, renal excretion is Urine.

Indications

Nimetazepam is primarily indicated in conditions like Insomnia.

Contraindications

Nimetazepam is contraindicated in conditions like Myasthenia gravis, Narrow-angle glaucoma, Hypersensitivity.

Dosage

None recorded.

Drug Interactions

Unknown1 interaction

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Nimetazepam is known to cause more or less tolerable side effects which are usually transient. These include Abdominal pain, Anorexia , Confusion, Diaphoresis, Diarrhea, Dizziness, Drowsiness, Excitation , Headache, Irritability, Nausea and vomiting, Nervousness, Redness, Skin rashes, Stiffiness, Tinnitus, Tremor.

Warnings / Precautions

Should be use with caution in patients with cardiac, hepatic, renal disorder, organic disorder in brain.

Interference in Pathology

Nimetazepam may interfere in the diagnosis of Elevations of GOTand GPT.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Tabs

3 mg

Storage Conditions

Nimetazepam should be stored .

Drug Classification

1.24.3 — Drugs used in anxiety and sleep disorders

Manufacturers

Manufacturers of Nimetazepam in Pakistan:

Zafa